---
figid: PMC7759095__gr4_lrg
figlink: pmc/articles/PMC7759095/figure/f0020/
number: F4
caption: Schematic representation of SARS-CoV-2 infection and signaling pathways as
  potential targets for treatment. SARS-CoV-2 binds to ACE2 and TMPRSS2 receptors
  through the S protein resulting in viral-host membrane fusion. Umifenovir and camostat
  mesylate inhibit the fusion process of viral entry. Virus enters the cells by endocytosis,
  and chloroquine and hydroxychloroquine inhibit the endosomal acidification and interfere
  with glycosylation of ACE2. The viral RNA is released and translated to essential
  viral polyproteins, 3CLpro and PLpro. Lopinavir/Ritonavir inhibits the activity
  of 3CLpro. Viral replication requires the RNA polymerase and remdesivir incorporates
  into nascent viral RNA causing RNA synthesis arrest, preventing viral replication.
  SARS-CoV-2 infection induces a massive release of cytokines including IL6, IL-1β,
  and IL-1 and increases the activation of NF-κB and JAK-STAT signaling pathways.
  Tocilizumab and sarilumab bind to membrane and soluble IL-6 receptors suppressing
  the JAK-STAT signaling pathway and attenuating inflammatory processes. Baricitinib
  and ruxolitinib inhibit the kinase activities of JAK1 and JAK2 and anakinra, an
  IL-1 receptor antagonist, reduces hyperinflammation and respiratory distress.
pmcid: PMC7759095
papertitle: 'COVID-19 vaccines: The status and perspectives in delivery points of
  view.'
reftext: Jee Young Chung, et al. Adv Drug Deliv Rev. 2020 Dec 24 ;170:1-25.
pmc_ranked_result_index: '21256'
pathway_score: 0.9058061
filename: gr4_lrg.jpg
figtitle: SARS-CoV-2 infection and signaling pathways as potential targets for treatment
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7759095__gr4_lrg.html
  '@type': Dataset
  description: Schematic representation of SARS-CoV-2 infection and signaling pathways
    as potential targets for treatment. SARS-CoV-2 binds to ACE2 and TMPRSS2 receptors
    through the S protein resulting in viral-host membrane fusion. Umifenovir and
    camostat mesylate inhibit the fusion process of viral entry. Virus enters the
    cells by endocytosis, and chloroquine and hydroxychloroquine inhibit the endosomal
    acidification and interfere with glycosylation of ACE2. The viral RNA is released
    and translated to essential viral polyproteins, 3CLpro and PLpro. Lopinavir/Ritonavir
    inhibits the activity of 3CLpro. Viral replication requires the RNA polymerase
    and remdesivir incorporates into nascent viral RNA causing RNA synthesis arrest,
    preventing viral replication. SARS-CoV-2 infection induces a massive release of
    cytokines including IL6, IL-1β, and IL-1 and increases the activation of NF-κB
    and JAK-STAT signaling pathways. Tocilizumab and sarilumab bind to membrane and
    soluble IL-6 receptors suppressing the JAK-STAT signaling pathway and attenuating
    inflammatory processes. Baricitinib and ruxolitinib inhibit the kinase activities
    of JAK1 and JAK2 and anakinra, an IL-1 receptor antagonist, reduces hyperinflammation
    and respiratory distress.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - ACE
  - TMPRSS2
  - ACE2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF5
  - TRAF6
  - TRAF4
  - TRAF7
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - IL18
  - IL4
  - Umifenovir
  - mesylate
  - Choloroquine
  - Hydroxychloroquine
  - Ruxolitinib
  - Baricitinib
  - Lopinavir
  - Ritonavir
genes:
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: ACE
  symbol: ACE
  source: hgnc_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: TMPRSS2
  symbol: TMPRSS2
  source: hgnc_symbol
  hgnc_symbol: TMPRSS2
  entrez: '7113'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF1
  entrez: '7185'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF4
  entrez: '9618'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF7
  entrez: '84231'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL4
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
chemicals:
- word: Umifenovir
  source: MESH
  identifier: C086979
- word: mesylate
  source: MESH
  identifier: D008698
- word: Choloroquine
  source: ''
  identifier: ''
- word: Hydroxychloroquine
  source: MESH
  identifier: D006886
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Baricitinib
  source: MESH
  identifier: C000596027
- word: Lopinavir
  source: MESH
  identifier: D061466
- word: Ritonavir
  source: MESH
  identifier: D019438
diseases: []
figid_alias: PMC7759095__F4
redirect_from: /figures/PMC7759095__F4
figtype: Figure
---
